#eli-lilly
#eli-lilly

Europe news

In surprise move Wegovy-maker Novo Nordisk ousts CEO amid sagging sales

NYC startup

Novo Nordisk Is Getting Absolutely Destroyed

Medicine

Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelms

fromAbove the Law

2 days ago

Intellectual property law

Patenting Privation (Part III): Empowering Revenge - Above the Law

Europe news

In surprise move Wegovy-maker Novo Nordisk ousts CEO amid sagging sales

NYC startup

Novo Nordisk Is Getting Absolutely Destroyed

Medicine

Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelms

more#novo-nordisk

#pharmaceuticals

Business intelligence

This Growth Stock Surged 63% in 2024. Here's Why 2025 Could Bring An Even Bigger Gain.

Eli Lilly stock has gained 63% in 2024, primarily due to the success of its Mounjaro weight-loss drug.

Healthcare

New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.

Weight-loss drugs are expensive due to the high development costs and the limited time to recoup investment before patents expire.

Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic

Eli Lilly's orforglipron shows significant weight loss for Type 2 diabetes patients, potentially rivaling injectable medications.

Lilly's shares surged 15% following promising clinical trial results for orforglipron.

NYC startup

Eli Lilly's New Weight Loss Drug May Have the Worst Name in Pharmaceutical History

Retirement

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (May 2025)

Business intelligence

This Growth Stock Surged 63% in 2024. Here's Why 2025 Could Bring An Even Bigger Gain.

Eli Lilly stock has gained 63% in 2024, primarily due to the success of its Mounjaro weight-loss drug.

Healthcare

New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.

Weight-loss drugs are expensive due to the high development costs and the limited time to recoup investment before patents expire.

Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic

Eli Lilly's orforglipron shows significant weight loss for Type 2 diabetes patients, potentially rivaling injectable medications.

Lilly's shares surged 15% following promising clinical trial results for orforglipron.

NYC startup

Eli Lilly's New Weight Loss Drug May Have the Worst Name in Pharmaceutical History

Retirement

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (May 2025)

Eli Lilly Will Be the Next $1 Trillion Stock

Eli Lilly aims to become the first healthcare company with a $1 trillion market cap, spurred by its GLP-1 therapy leadership.

Orforglipron's success in trials positions Lilly for significant market growth in obesity and diabetes management.

6 months ago

Business

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Cryptocurrency

Here's Why Eli Lilly (NYSE: LLY). Fidelity National (NYSE: FIS) and Diamondback Energy (Nasdaq: FANG) Are Soaring Today

Business

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Startup companies

These 2 Dividend Giants Are at 52-Week Lows. Time to Buy?

London startup

Eli Lilly Will Be the Next $1 Trillion Stock

Eli Lilly aims to become the first healthcare company with a $1 trillion market cap, spurred by its GLP-1 therapy leadership.

Orforglipron's success in trials positions Lilly for significant market growth in obesity and diabetes management.

6 months ago

Business

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Cryptocurrency

Here's Why Eli Lilly (NYSE: LLY). Fidelity National (NYSE: FIS) and Diamondback Energy (Nasdaq: FANG) Are Soaring Today

Business

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Startup companies

These 2 Dividend Giants Are at 52-Week Lows. Time to Buy?

more#stock-market

#zepbound

fromwww.mercurynews.com

Medicine

Lilly sells Zepbound vials at 50% discount to meet weight loss drug demand

Medicine

Eli Lilly just halved the price of its weight-loss drug - declaring war on the booming market of knock-offs

Medicine

Eli Lilly just made its weight-loss drug cheaper with a simple design tweak

fromwww.npr.org

Alternative medicine

Eli Lilly sues companies selling alternative versions of its weight loss drug

Medicine

Here's how Eli Lilly is fixing its Zepbound supply shortage

fromArs Technica

Medicine

Eli Lilly raises price of Zepbound while trumpeting discount on starter vials

fromwww.mercurynews.com

Medicine

Lilly sells Zepbound vials at 50% discount to meet weight loss drug demand

Medicine

Eli Lilly just halved the price of its weight-loss drug - declaring war on the booming market of knock-offs

Medicine

Eli Lilly just made its weight-loss drug cheaper with a simple design tweak

fromwww.npr.org

Alternative medicine

Eli Lilly sues companies selling alternative versions of its weight loss drug

Medicine

Here's how Eli Lilly is fixing its Zepbound supply shortage

fromArs Technica

Medicine

Eli Lilly raises price of Zepbound while trumpeting discount on starter vials

What to Know About Eli Lilly's Daily Pill for Weight Loss

Eli Lilly's orforglipron offers a potential oral treatment for obesity and diabetes, expanding access beyond current injected options.

Weight loss in a pill? Eli Lilly just took a big step closer to making it happen

Orforglipron, a new oral GLP-1 drug from Eli Lilly, may transform obesity treatment by offering a non-injection alternative.

Everything to know about the new weight loss pill that works as well as Ozempic - and when you can get it

Eli Lilly's orforglipron offers a stab-free treatment for diabetes and obesity, with potential FDA approval enhancing its market presence.

fromwww.nytimes.com

What to Know About Eli Lilly's Daily Pill for Weight Loss

Eli Lilly's orforglipron offers a potential oral treatment for obesity and diabetes, expanding access beyond current injected options.

Weight loss in a pill? Eli Lilly just took a big step closer to making it happen

Orforglipron, a new oral GLP-1 drug from Eli Lilly, may transform obesity treatment by offering a non-injection alternative.

Everything to know about the new weight loss pill that works as well as Ozempic - and when you can get it

Eli Lilly's orforglipron offers a stab-free treatment for diabetes and obesity, with potential FDA approval enhancing its market presence.

more#orforglipron

#pharmaceutical-industry

US politics

Eli Lilly plans $27bn in new plants as Trump threatens pharma tariffs

Eli Lilly plans to invest $27 billion in new US plants, creating over 3,000 skilled jobs and responding to potential drug import tariffs.

London startup

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (April 2025)

US politics

Eli Lilly plans $27bn in new plants as Trump threatens pharma tariffs

Eli Lilly plans to invest $27 billion in new US plants, creating over 3,000 skilled jobs and responding to potential drug import tariffs.

more#pharmaceutical-industry

London startup

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (April 2025)

Exercise

fromwww.nytimes.com

2 months ago

Eli Lilly Drug Reduces Mysterious Lp(a) Particle Involved in Heart Attack Risk

Eli Lilly's experimental drug lepodisiran significantly reduces harmful Lp(a) levels in the blood, potentially aiding cardiovascular health.

Startup companies